Content about Teva Pharmaceutical Industries

October 4, 2010
Watson confirms patent challenge for generic Azilect

Generic drug maker Watson Pharmaceuticals is seeking approval for a generic treatment for Parkinson’s disease,...

September 30, 2010
Teva unveils mid-stage clinical trial results for MS drug

Teva Pharmaceutical Industries and Active Biotech announced promising results from a mid-stage trial of laquinimod,...

September 29, 2010
Teva, OncoGenex commence phase-3 trial for advanced prostate cancer drug

Teva Pharmaceutical Industries and OncoGenex Pharmaceuticals have started a late-stage clinical trial of an investigative...

September 26, 2010
Biosimilars’ future predicted to be as uncontroversial as generics

Biosimilars, biogenerics, follow-on biologics—whatever the designation one prefers for knockoffs of biotech drugs—they will soon...

September 26, 2010
NACDS conference discusses patent cliff, future of generics

Winc Design is launching its Charlie Banana brand of environmentally friendly cloth diapers and baby...

September 26, 2010
REPORTERS Notebook

Greenstone announced the launch of an authorized generic version of the Alzheimer’s disease drug Aricept...

September 26, 2010
Senate, courts debate legality of patent settlement deals

For all its successes, the generic drug industry has had a lot to worry about...

September 21, 2010
Teva sues Mylan for patent infringement over Copaxone

Teva filed a complaint against a generic drug maker this week, asserting four patents for...

September 9, 2010
Appeals court upholds decision to OK 'pay-for-delay' deals

The federal government got a kick in the face Thursday as an appeals court ruled...

September 9, 2010
Generic versions of Copaxone hit roadblock

Efforts by two generic drug makers to market a generic version of a drug for...

September 1, 2010
Teva markets AcuDial generic

Teva Pharmaceuticals has launched a generic treatment for epileptic seizures....

August 30, 2010
IMS Health exec to NACDS conference attendees: Expect opportunities, uncertainties for drug market

The U.S. drug market will present opportunities as well as uncertainties over the next decade,...

August 25, 2010
Teva launches generic version of popular antidepressant

Teva Pharmaceutical Industries has launched a generic version of a weekly formulation of a popular...

August 22, 2010
Teva introduces generic drug that lowers blood pressure

Teva Pharmaceutical Industries has introduced a generic drug for lowering patients’ blood pressure, the world’s...

August 15, 2010
Meda ventures into generic drugs

A lot of generic drug companies have conducted business in the branded drug market on...

August 9, 2010
Teva completes Ratiopharm acquisition

Israeli drug maker Teva Pharmaceutical Industries has finished its $5 billion acquisition of German generic...

August 2, 2010
Teva gets closer to completing Ratiopharm acquisition

Teva Pharmaceutical Industries got closer to finishing its $5 billion acquisition of German drug maker...

July 21, 2010
Forest, Merz announce Namenda patent settlements

Several generic drug makers have settled with Forest Labs and German drug maker Merz Pharma...

July 13, 2010
Teva launches generic Amerge

Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said....

June 30, 2010
Teva launches generic Effexor XR

Teva Pharmaceutical Industries has launched the first generic version of a drug used for treating...

June 29, 2010
Court upholds Crestor patent

The U.S. District Court for the District of Delaware has upheld the patent on a...

June 28, 2010
Teva's generic Effexor XR receives regulatory approval

The Food and Drug Administration has approved the first generic version of an extended-release antidepressant...

June 17, 2010
Teva admits making false claims about contraceptive

Teva Pharmaceutical Industries admitted before a federal court Thursday to making false statements about the...

June 14, 2010
Teva, subsidiaries accused of patent infringement, false advertising

Two divisions of Bayer have filed a lawsuit against Teva Pharmaceutical Industries and two of...

June 13, 2010
Teva's investment in Andromeda will fund diabetes treatment

Teva Pharmaceutical Industries has invested $11.9 million in Andromeda Biotech, a company that develops diabetes...

© 2013 Drug Store News. All Rights Reserved.